FAM
COLL icon

Fulcrum Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Fulcrum Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44K Buy
+40
New +$1.37K ﹤0.01% 908

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Fulcrum Asset Management's COLL Position: Q2 2026 in Review

Fulcrum Asset Management opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 40 shares worth $1.44K. The stake represents ﹤0.01% of the portfolio and ranks #908 among its holdings.

279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Fulcrum Asset Management held 40 shares of Collegium Pharmaceutical worth $1.44K as of Q2 2026.
  • Collegium Pharmaceutical was a new Fulcrum Asset Management position in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Fulcrum Asset Management's portfolio in Q2 2026, its #908 holding.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Fulcrum Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.